Literature DB >> 22266017

Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

J Eva Selfridge1, Lezi E, Jianghua Lu, Russell H Swerdlow.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease that affects a staggering percentage of the aging population and causes memory loss and cognitive decline. Mitochondrial abnormalities can be observed systemically and in brains of patients suffering from AD, and may account for part of the disease phenotype. In this review, we summarize some of the key findings that indicate mitochondrial dysfunction is present in AD-affected subjects, including cytochrome oxidase deficiency, endophenotype data, and altered mitochondrial morphology. Special attention is given to recently described perturbations in mitochondrial autophagy, fission-fusion dynamics, and biogenesis. We also briefly discuss how mitochondrial dysfunction may influence amyloidosis in Alzheimer's disease, why mitochondria are a valid therapeutic target, and strategies for addressing AD-specific mitochondrial dysfunction.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22266017      PMCID: PMC3337963          DOI: 10.1016/j.nbd.2011.12.057

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  193 in total

1.  Role and regulation of starvation-induced autophagy in the Drosophila fat body.

Authors:  Ryan C Scott; Oren Schuldiner; Thomas P Neufeld
Journal:  Dev Cell       Date:  2004-08       Impact factor: 12.270

2.  The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.

Authors:  Camilla A Hansson Petersen; Nyosha Alikhani; Homira Behbahani; Birgitta Wiehager; Pavel F Pavlov; Irina Alafuzoff; Ville Leinonen; Akira Ito; Bengt Winblad; Elzbieta Glaser; Maria Ankarcrona
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

3.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

4.  Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

Authors:  Julie St-Pierre; Stavit Drori; Marc Uldry; Jessica M Silvaggi; James Rhee; Sibylle Jäger; Christoph Handschin; Kangni Zheng; Jiandie Lin; Wenli Yang; David K Simon; Robert Bachoo; Bruce M Spiegelman
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

5.  Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.

Authors:  Lisa Mosconi; Lidia Glodzik; Rachel Mistur; Pauline McHugh; Kenneth E Rich; Elizabeth Javier; Schantel Williams; Elizabeth Pirraglia; Susan De Santi; Pankaj D Mehta; Raymond Zinkowski; Kaj Blennow; Domenico Pratico; Mony J de Leon
Journal:  Biol Psychiatry       Date:  2010-11-15       Impact factor: 13.382

6.  Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.

Authors:  Yoelvis García-Mesa; Juan Carlos López-Ramos; Lydia Giménez-Llort; Susana Revilla; Rafael Guerra; Agnès Gruart; Frank M Laferla; Rosa Cristòfol; José M Delgado-García; Coral Sanfeliu
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 7.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

8.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

Authors:  Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph D Buxbaum; Giulio M Pasinetti
Journal:  Arch Neurol       Date:  2009-03

9.  Cytochrome c oxidase is decreased in Alzheimer's disease platelets.

Authors:  Sandra Morais Cardoso; M Teresa Proença; Sancha Santos; Isabel Santana; Catarina R Oliveira
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  49 in total

1.  Investigating heart-specific toxicity of amyloidogenic immunoglobulin light chains: A lesson from C. elegans.

Authors:  Luisa Diomede; Paola Rognoni; Francesca Lavatelli; Margherita Romeo; Andrea di Fonzo; Claudia Foray; Fabio Fiordaliso; Giovanni Palladini; Veronica Valentini; Vittorio Perfetti; Mario Salmona; Giampaolo Merlini
Journal:  Worm       Date:  2014-10-30

2.  Mitochondrial accumulation of amyloid β (Aβ) peptides requires TOMM22 as a main Aβ receptor in yeast.

Authors:  Wenxin Hu; Zhiming Wang; Hongjin Zheng
Journal:  J Biol Chem       Date:  2018-06-20       Impact factor: 5.157

Review 3.  Autophagy modulation for Alzheimer's disease therapy.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

Review 4.  Quality control of the mitochondrial proteome.

Authors:  Jiyao Song; Johannes M Herrmann; Thomas Becker
Journal:  Nat Rev Mol Cell Biol       Date:  2020-10-22       Impact factor: 94.444

5.  The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging.

Authors:  William K Gottschalk; Michael W Lutz; Yu Ting He; Ann M Saunders; Daniel K Burns; Allen D Roses; Ornit Chiba-Falek
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014-11

Review 6.  ER-stress in Alzheimer's disease: turning the scale?

Authors:  Kristina Endres; Sven Reinhardt
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

7.  Pretreatment of chemically-synthesized Aβ42 affects its biological activity in yeast.

Authors:  Afsaneh Porzoor; Joanne M Caine; Ian G Macreadie
Journal:  Prion       Date:  2014       Impact factor: 3.931

8.  Proteomic Analysis and Biochemical Correlates of Mitochondrial Dysfunction after Low-Intensity Primary Blast Exposure.

Authors:  Hailong Song; Mei Chen; Chen Chen; Jiankun Cui; Catherine E Johnson; Jianlin Cheng; Xiaowan Wang; Russell H Swerdlow; Ralph G DePalma; Weiming Xia; Zezong Gu
Journal:  J Neurotrauma       Date:  2019-01-14       Impact factor: 5.269

Review 9.  Estrogen receptor β in Alzheimer's disease: From mechanisms to therapeutics.

Authors:  Liqin Zhao; Sarah K Woody; Anindit Chhibber
Journal:  Ageing Res Rev       Date:  2015-08-22       Impact factor: 10.895

10.  Polo-like kinase 2 activates an antioxidant pathway to promote the survival of cells with mitochondrial dysfunction.

Authors:  Jie Li; Wenzhe Ma; Ping-yuan Wang; Paula J Hurley; Fred Bunz; Paul M Hwang
Journal:  Free Radic Biol Med       Date:  2014-06-02       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.